Karolinska Development AB (KDEVF)
0.2576
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Karolinska Development Total Liabilities (Quarterly): 1.233M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.233M |
December 31, 2023 | 1.149M |
September 30, 2023 | 0.7763M |
June 30, 2023 | 0.8955M |
March 31, 2023 | 0.7709M |
December 31, 2022 | 0.9794M |
September 30, 2022 | 0.9079M |
June 30, 2022 | 1.012M |
March 31, 2022 | 1.119M |
December 31, 2021 | 15.27M |
September 30, 2021 | 15.51M |
June 30, 2021 | 10.67M |
March 31, 2021 | 10.14M |
December 31, 2020 | 10.97M |
September 30, 2020 | 11.58M |
June 30, 2020 | 12.66M |
March 31, 2020 | 12.34M |
December 31, 2019 | 17.01M |
September 30, 2019 | 53.72M |
June 30, 2019 | 57.20M |
March 31, 2019 | 55.27M |
December 31, 2018 | 55.50M |
September 30, 2018 | 48.41M |
June 30, 2018 | 46.10M |
March 31, 2018 | 48.60M |
Date | Value |
---|---|
December 31, 2017 | 48.44M |
September 30, 2017 | 47.26M |
June 30, 2017 | 43.74M |
March 31, 2017 | 40.48M |
December 31, 2016 | 45.06M |
September 30, 2016 | 46.27M |
June 30, 2016 | 45.37M |
March 31, 2016 | 46.19M |
December 31, 2015 | 43.59M |
September 30, 2015 | 42.72M |
June 30, 2015 | 42.66M |
March 31, 2015 | 44.34M |
December 31, 2014 | 8.362M |
September 30, 2014 | 4.072M |
June 30, 2014 | 3.15M |
March 31, 2014 | 3.087M |
December 31, 2013 | 3.434M |
September 30, 2013 | 4.065M |
June 30, 2013 | 3.580M |
March 31, 2013 | 3.759M |
December 31, 2012 | 3.369M |
September 30, 2012 | 33.84M |
June 30, 2012 | 23.53M |
March 31, 2012 | 24.91M |
December 31, 2011 | 24.95M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.7709M
Minimum
Mar 2023
57.20M
Maximum
Jun 2019
11.80M
Average
10.40M
Median
Total Liabilities (Quarterly) Benchmarks
Abliva AB | 1.667M |
Calliditas Therapeutics AB | 151.43M |
Oncopeptides AB | 14.80M |
Olink Holding AB | 81.33M |
BioInvent International AB | 9.011M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 118.29M |
Shareholders Equity (Quarterly) | 117.06M |
Current Ratio | 6.162 |